PLOD1/2/3 can catalyze the formation of hydroxylysine residues in the -Xaa-Lys-Gly- sequence in collagen, which can serve as an attachment point between collagen molecules and improve stability, and has recently been recognized as an important biomarker for cancer prognosis [54, 55]. This evidence concerns the gene PLOD1 and cancer.